Warrant

A warrant is the security granting the holder the right to purchase shares at a fixed exercise price for a defined period. Similar in mechanics to a stock option but issued to non-employees (banks, lenders, strategic partners, advisors), warrants typically run 5-10 years and are commonly attached to venture debt deals, strategic partnership agreements, and bank facilities. It is the structural analog of a stock option for non-employee parties and a frequent component of late-stage financing structures.

The warrant mechanic:

• Grant: company issues warrant to the holder, specifying share count, exercise price, expiration date, and any other terms (cashless exercise rights, transferability, etc.).
• Exercise: during the warrant's term, the holder can exercise some or all of the warrant by paying the exercise price (cash exercise) or using cashless exercise mechanics if permitted.
• Conversion to shares: upon exercise, the holder receives common or preferred shares as specified by the warrant.
• Expiration: if not exercised by the expiration date, the warrant expires worthless.

Common contexts where warrants appear in venture-backed companies:

• Venture debt: lenders typically receive warrants for 2-15% of the loan principal as "warrant coverage." Example: $5M venture debt loan with 5% warrant coverage gives the lender warrants worth $250K of common (or preferred) at a defined exercise price. The warrants are the lender's upside compensation for taking credit risk on a still-uncertain company.
• Strategic partnerships: large customer or distribution partners sometimes receive warrants tied to performance milestones (revenue, distribution targets) as part of the partnership economics.
• Bank facilities: lines of credit and term loans sometimes carry warrants as part of the lender's compensation, similar to venture debt.
• Marketing or advisor relationships: less common today but historically used to compensate advisors and marketing partners with upside in lieu of cash.
• Bridge financings: short-term bridge notes sometimes include warrant coverage as additional compensation for the bridge lenders.

Warrant terms that matter:

• Exercise price: typically equal to the most recent preferred price (when the warrant is tied to a financing) or 409A common FMV at issuance. Below-FMV warrants can create tax issues for the holder.
• Term: typically 5-10 years; longer terms are more valuable to the holder.
• Cashless exercise: standard at most warrants; allows the holder to net out the exercise price against share value rather than paying cash.
• Anti-dilution: warrants may include weighted-average or full-ratchet anti-dilution protection. Negotiate carefully.
• Coverage amount: in venture debt, this is the key economic term. 5-15% is typical depending on company stage and risk.

Tax treatment of warrants: generally treated as capital assets for the holder. No tax at grant or vesting (warrants don't vest in the option sense). Tax at exercise if cash exercise: the bargain element may be ordinary income (for service-provider warrants) or capital basis (for investment warrants). Tax on sale of underlying shares: capital gain (long-term if held more than one year from exercise). The tax mechanic depends on the warrant's purpose and the holder's status.

Ryan's Take

Warrants are the equity-side of venture debt deals and the common compensation for strategic partners. The key economic term to negotiate: warrant coverage in venture debt deals. 5-15% is the typical range; founders should push for the lower end (5-8%) on stronger companies and accept higher (10-15%) only when the credit risk justifies it. The other key term: the exercise price. Insisting on common-FMV exercise (rather than preferred-price exercise) is meaningfully better for the company because common FMV is typically 20-30% below preferred. Strategic partnership warrants are more situational; negotiate the milestone triggers carefully so warrants only vest on actual performance, not aspirational targets. Lawyers handle the boilerplate but the economic terms (coverage, exercise price, term, anti-dilution) are real negotiation points.

What founders get wrong: Accepting venture debt warrant coverage as a non-negotiable term ("it's standard at 10%") rather than negotiating based on the company's specific risk profile. Strong companies can typically negotiate 5-8% coverage; weaker companies pay 10-15%. The right discipline: get quotes from multiple lenders, compare warrant coverage as a key economic term, and push for the lower end where the company's metrics justify it. The cost difference between 5% and 10% coverage on a $10M loan is $500K of equity value, which compounds materially through the life of the company.

Related: [Stock Option] · [Venture Debt] · [Common Stock] · [Preferred Stock] · [Cap Table]

FAQ

What is a warrant? A security granting the holder the right to purchase a defined number of shares at a fixed exercise price for a defined period (typically 5-10 years). Similar to a stock option but typically issued to non-employees (banks, lenders, strategic partners, advisors) and with different tax treatment.

Where do warrants commonly appear? Venture debt (lenders get warrants as additional compensation), strategic partnerships (partners receive warrants tied to performance milestones), bank facilities (similar to venture debt), advisor and marketing relationships (less common today), and bridge financings (short-term notes with warrant coverage).

What's "warrant coverage" in venture debt? The amount of warrants the lender receives expressed as a percentage of the loan principal. 5-15% is typical; 5-8% for stronger companies, 10-15% for higher-risk companies. The warrant exercise price is typically the most recent preferred price or current 409A common FMV. Founders should negotiate to push coverage toward the lower end.